Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

GlaxoSmithKline Further Extends Bid for Human Genome Sciences

By Pharmaceutical Processing | July 2, 2012

GlaxoSmithKline announced Friday the extension of its $2.6-billion tender offer to acquire all outstanding shares of Human Genome Sciences to July 20, from a previous date of June 29. The UK drugmaker noted that as of June 28, approximately 375 526 shares had been tendered to the offer, although Human Genome Sciences indicated that this represents less than 1 percent of its shares.

GlaxoSmithKline said that the $13.00-per share cash bid, which was originally set to end on June 7 before being extended, will now expire after the July 16 deadline set by Human Genome Sciences for the submission of acquisition proposals under its strategic review process. “Extension of the tender offer…will provide [Human Genome Sciences] shareholders the opportunity to evaluate the outcome of the…[Human Genome Sciences] board’s process relative to [our] offer,” the UK company indicated.

GlaxoSmithKline added that “based on circumstances at that time, [it] will consider all available options regarding its offer but can make no assurance that the tender offer will be further extended.” However, the UK drugmaker indicated that it “remains willing to meet and review its offer” with Human Genome Sciences.

 

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE